Arbutus Biopharma Corp
ABUS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001447028
No open-market purchases or sales by Arbutus Biopharma Corp insiders were filed in the last 90 days; 176 institutions reported holding it in 13F filings for Q2 2026, worth $674.9M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Arbutus Biopharma Corp as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 123
- +24 vs. Q3 2021
- Shares held
- 39.7M
- +5.02M (+14.5%) vs. Q3 2021
- Total value
- $154.4M
- +$5.61M (+3.8%) vs. Q3 2021
- New holders
- 43
- 39 more added
- Sold out
- 19
- 22 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ABUS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 176 | $674.9M |
| Q1 2026 | 167 | $625.4M |
| Q4 2025 | 172 | $586.9M |
| Q3 2025 | 166 | $536.4M |
| Q2 2025 | 163 | $365.0M |
| Q1 2025 | 168 | $390.1M |
| Q4 2024 | 154 | $340.3M |
| Q3 2024 | 144 | $389.2M |
| Q2 2024 | 131 | $298.4M |
| Q1 2024 | 119 | $215.2M |
| Q4 2023 | 112 | $197.4M |
| Q3 2023 | 99 | $143.8M |
| Q2 2023 | 111 | $152.4M |
| Q1 2023 | 122 | $189.3M |
| Q4 2022 | 114 | $126.3M |
| Q3 2022 | 127 | $89.1M |
| Q2 2022 | 113 | $120.0M |
| Q1 2022 | 119 | $130.6M |
| Q4 2021 | 123 | $154.4M |
| Q3 2021 | 100 | $149.8M |
| Q2 2021 | 91 | $87.6M |
| Q1 2021 | 94 | $86.5M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Arbutus Biopharma Corp; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of New York Mellon Corp | 352,953 | $1.37M | 0.00% | +96,032+37.4% | Added |
| Jane Street Group, LLC | 352,880 | $1.37M | 0.00% | +130,119+58.4% | Added |
| Group One Trading, L.P. | 358,522 | $1.40M | 0.03% | +106,297+42.1% | Added |
| Prudential Financial Inc | 405,360 | $1.58M | 0.00% | +405,360 | New |
| Boothbay Fund Management, LLC | 458,642 | $1.78M | 0.06% | +298,642+186.7% | Added |
| Primecap Management Co | 470,000 | $1.83M | 0.00% | −30,000−6.0% | Reduced |
| Susquehanna International Group, LLP | 516,915 | $2.01M | 0.00% | −145,688−22.0% | Reduced |
| Great Point Partners LLC | 668,907 | $2.60M | 0.58% | +668,907 | New |
| Goldman Sachs Group Inc | 693,271 | $2.70M | 0.00% | +406,635+141.9% | Added |
| Bank of America Corp | 707,097 | $2.75M | 0.00% | +90,512+14.7% | Added |
| Northern Trust Corp | 734,468 | $2.86M | 0.00% | +33,964+4.8% | Added |
| Two Seas Capital LP | 825,569 | $3.21M | 2.46% | +825,569 | New |
| Two Sigma Investments, LP | 885,537 | $3.44M | 0.01% | +155,239+21.3% | Added |
| Brookfield Asset Management Inc. | 1,192,889 | $4.64M | 0.02% | +1,192,889 | New |
| Advisor Group Holdings, Inc. | 1,364,894 | $5.31M | 0.01% | +3300.0% | Added |
| Geode Capital Management, LLC | 1,669,624 | $6.49M | 0.00% | +129,193+8.4% | Added |
| State Street Corp | 1,683,829 | $6.55M | 0.00% | +27,446+1.7% | Added |
| Hudson Bay Capital Management LP | 1,805,700 | $7.02M | 0.08% | +5,700+0.3% | Added |
| Nuveen Asset Management, LLC | 2,011,809 | $7.89M | 0.00% | +892,198+79.7% | Added |
| RTW Investments, LP | 2,504,493 | $9.74M | 0.14% | −2,228,830−47.1% | Reduced |
| Millennium Management LLC | 3,039,185 | $11.8M | 0.01% | +2,017,490+197.5% | Added |
| Vanguard Group Inc | 4,555,494 | $17.7M | 0.00% | +789,515+21.0% | Added |
| BlackRock Inc. | 6,166,349 | $24.0M | 0.00% | +231,146+3.9% | Added |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −895,200−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −496,172−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −397,088−100.0% | Sold out |
| Cowen and Company, LLC | 0 | $0 | 0.00% | −249,215−100.0% | Sold out |
| Kerrisdale Advisers, LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Apis Capital Advisors, LLC | 0 | $0 | 0.00% | −70,000−100.0% | Sold out |
| Shay Capital LLC | 0 | $0 | 0.00% | −60,000−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −22,184−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −19,065−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −18,724−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −16,499−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −10,600−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −2,265−100.0% | Sold out |
| JFS Wealth Advisors, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Arkadios Wealth Advisors | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −700−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −619−100.0% | Sold out |
| NEXT Financial Group, Inc | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Marshall Wace North America L.P. | – | – | – | – | Not filed |